Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Illumina

Explore full profile

Integrated systems for genetic and biological analysis.

San Diego, United StatesFounded 1998Biotech & Life Sciences
Valuation $32B Market cap · Aug/2026
Revenue $4.61B Latest reported FY
EBITDA $1.30B Latest reported FY

At a glance

Founded
1998
Headquarters
San Diego, United States
Listing
IPO 2000
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tierThoroughbred$100M+ revenue

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • Dow
  • Tredegar Investments
  • CW Group Holdings
  • Chevron Technology Ventures
  • State Farm
  • Chase Capital Partners
  • The Tisch Family
  • Lombard Odier

Series B and later4 investors entered at this stage

Employees mapped 9,679 incl. 92 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 79 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 12 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
49 countries with
team presence
🇺🇸 United States59%
🇸🇬 Singapore11.9%
🇬🇧 United Kingdom9.1%
🇮🇳 India3.2%
🇨🇳 China2.3%
Top 5 of 49 shown
Web traffic by country
830K monthly visits
across markets
🇺🇸 United States41.2%
🇬🇧 United Kingdom6.4%
🇯🇵 Japan3.8%
🇩🇪 Germany3.1%
🇹🇭 Thailand3%
Top 5 markets shown

Patents

Estimated portfolio value
$2.4B

1,980 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Illumina was the backer or acquirer, 2006–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

145 deals across Illumina's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Illumina deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Illumina's portfolio, mapped.

        Stage
        Period
        145 of 145 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Illumina on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Illumina on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.